Literature DB >> 9097761

Angiogenesis inhibition in age-related macular degeneration.

R J D'Amato, A P Adamis.   

Abstract

Mesh：

Year:  1995        PMID： 9097761

Source DB:  PubMed          Journal:  Ophthalmology        ISSN： 0161-6420            Impact factor:   12.079


× No keyword cloud information.
  9 in total

1.  Pharmacokinetics and safety of an anti-vascular endothelial growth factor aptamer (NX1838) following injection into the vitreous humor of rhesus monkeys.

Authors:  D W Drolet; J Nelson; C E Tucker; P M Zack; K Nixon; R Bolin; M B Judkins; J A Farmer; J L Wolf; S C Gill; R A Bendele
Journal:  Pharm Res       Date:  2000-12       Impact factor: 4.200

2.  Increased expression of angiogenic growth factors in age-related maculopathy.

Authors:  M Kliffen; H S Sharma; C M Mooy; S Kerkvliet; P T de Jong
Journal:  Br J Ophthalmol       Date:  1997-02       Impact factor: 4.638

3.  Overexpression of vascular endothelial growth factor (VEGF) in the retinal pigment epithelium leads to the development of choroidal neovascularization.

Authors:  K Spilsbury; K L Garrett; W Y Shen; I J Constable; P E Rakoczy
Journal:  Am J Pathol       Date:  2000-07       Impact factor: 4.307

4.  Galloyl Carbohydrates with Antiangiogenic Activity Mediated by Capillary Morphogenesis Gene 2 (CMG2) Protein Binding.

Authors:  Elisa G-Doyagüez; Paula Carrero; Andrés Madrona; Patricia Rodriguez-Salamanca; Belén Martínez-Gualda; María José Camarasa; María Luisa Jimeno; Philip R Bennallack; Jordan G Finnell; Tsz-Ming Tsang; Kenneth A Christensen; Ana San-Félix; Michael S Rogers
Journal:  J Med Chem       Date:  2019-04-09       Impact factor: 7.446

5.  Utilizing targeted gene therapy with nanoparticles binding alpha v beta 3 for imaging and treating choroidal neovascularization.

Authors:  Hani Salehi-Had; Mi In Roh; Andrea Giani; Toshio Hisatomi; Shintaro Nakao; Ivana K Kim; Evangelos S Gragoudas; Demetrios Vavvas; Samira Guccione; Joan W Miller
Journal:  PLoS One       Date:  2011-04-29       Impact factor: 3.240

6.  A FRET-based high throughput screening assay to identify inhibitors of anthrax protective antigen binding to capillary morphogenesis gene 2 protein.

Authors:  Michael S Rogers; Lorna M Cryan; Kaiane A Habeshian; Lauren Bazinet; Thomas P Caldwell; P Christine Ackroyd; Kenneth A Christensen
Journal:  PLoS One       Date:  2012-06-29       Impact factor: 3.240

7.  Alternate serotype adenovector provides long-term therapeutic gene expression in the eye.

Authors:  Melissa M Hamilton; Gordon A Byrnes; Jason G Gall; Douglas E Brough; C Richter King; Lisa L Wei
Journal:  Mol Vis       Date:  2008-12-30       Impact factor: 2.367

8.  Inhibition of choroidal neovascularization by topical application of angiogenesis inhibitor vasostatin.

Authors:  Shwu-Jiuan Sheu; Youn-Shen Bee; Yi-Ling Ma; Guei-Sheung Liu; Hsiu-Chen Lin; Tse-Liang Yeh; Jau-Chen Liou; Ming-Hong Tai
Journal:  Mol Vis       Date:  2009-09-18       Impact factor: 2.367

9.  A reproducible and quantifiable model of choroidal neovascularization induced by VEGF A165 after subretinal adenoviral gene transfer in the rabbit.

Authors:  Sylvie Julien; Florian Kreppel; Susanne Beck; Peter Heiduschka; Veronica Brito; Sven Schnichels; Stefan Kochanek; Ulrich Schraermeyer
Journal:  Mol Vis       Date:  2008-07-30       Impact factor: 2.367
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.